David P Schenkein
Director · 2 filings · Latest: Jun 5, 2026
Denali Therapeutics Inc.
Prime Medicine, Inc.
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|
DNLI | DAVID SCHENKEIN | — | Nov 11, 2024 | Proposed Sale | $31.35 | 59,441 | $1.9M | — |